Can Smoking Affect Weight Loss on Mounjaro or Wegovy?

The connection between smoking and body weight is more complicated than it first appears. Nicotine acts as a mild appetite suppressant and can slightly raise resting metabolic rate, which is why some people who stop smoking notice initial weight gain. However, these short-term metabolic effects do not translate into healthy or sustainable weight loss — and for people on a GLP-1 medicine such as Mounjaro (tirzepatide) or Wegovy (semaglutide), there are additional layers worth considering.

Appetite signals and food noise

GLP-1 receptor agonists work partly by influencing appetite-regulating pathways, helping to reduce feelings of hunger and what many people describe as food noise. Nicotine also suppresses appetite through separate pathways. The overlap is not well studied in clinical detail, and it is not possible to predict what this means for any individual — your prescriber or doctor is the right person to discuss this with, based on your full health picture.

Cardiovascular and metabolic considerations

Both Mounjaro and Wegovy are used in people who often have existing cardiovascular or metabolic risk factors. Smoking is independently associated with raised cardiovascular risk, reduced lung capacity, and chronic inflammation — all of which can affect how your body responds to lifestyle changes like increased activity, which is often an important part of a weight management programme. Many people find that understanding the link between smoking and weight loss outcomes helps them make more informed decisions in partnership with their healthcare team.

Progress that is hard to see

One practical challenge is that smoking can make it harder to interpret your own progress. Energy levels, physical stamina, and how your body tolerates exercise are all affected by smoking — meaning two people on the same medicine, eating similarly, may experience quite different results based on lifestyle factors alone. Tracking the full picture rather than just the scale number is genuinely important here. You can also read more about other factors that people research alongside GLP-1 medicines to understand the wider landscape of weight management.

Weight on a GLP-1 medicine rarely moves in a straight line, and isolating what is — and is not — driving your results takes more than just watching the scale. GLP Trackr's progress tracking and insights tools are built exactly for this kind of nuanced journey.

The weight and body tracking feature lets you log your weight, measurements, and weekly changes in one place, with charts that show your actual trend over time rather than just day-to-day fluctuation. Where smoking is a factor in your life, those trends — combined with energy, sleep, and activity data from your daily check-in — can start to reveal patterns that a single weekly weigh-in would miss entirely.

GLP Trackr's correlation explorer and insights can surface connections between the data points you log: how sleep quality, step count, or mood track alongside your weight movement. This kind of personalised view is genuinely useful to bring to a prescriber appointment, especially if you are navigating lifestyle factors like smoking alongside your medication.

You can find a broader overview of how to get the most from your journey in the GLP Trackr weight loss tracking guide.

GLP Trackr records and organises your data so you can have better conversations with your prescriber — it is not a substitute for their advice. If you have any concerns about how smoking may interact with your medication or overall health, please raise them with your prescriber or doctor, who knows your full history.

Ready to see your full journey in one place? Download GLP Trackr on the App Store or Google Play and start your free 7-day trial — no commitment needed.